International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

Affiliations

¹ Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Center, the Netherlands.
² Department of Radiotherapy and Oncology, University of Frankfurt, Germany.
³ Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
⁴ Department of Radiation Oncology, University Hospitals Leuven, Belgium.
⁵ Department of Radiotherapy, Mount Vernon Centre for Cancer Treatment, Northwood, London, United Kingdom.
⁶ Department of Radiology, Radiation Oncology and Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica S. Cuore, Rome, Italy.
⁷ Department of Oncology, Aarhus University Hospital, Denmark.
⁸ Department of Oncology, Oslo University Hospital, Norway.
⁹ Department of Oncology, Sorbonne University, Paris, France.
¹⁰ Department of Radiotherapy, Universidad de Navarra, Madrid, Spain.
¹¹ Department of Radiotherapy, Champalimaud Foundation, Lisbon, Portugal.
¹² Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
¹³ Department of Radiotherapy, Leeds Cancer Centre, University of Leeds, UK.

Comment

C A M Marijnen et al. Radiother Oncol. 2020 Jul.

. 2020 Jul:148:213-215.

doi: 10.1016/j.radonc.2020.03.039. Epub 2020 Apr 2.

¹ Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Center, the Netherlands.
² Department of Radiotherapy and Oncology, University of Frankfurt, Germany.
³ Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
⁴ Department of Radiation Oncology, University Hospitals Leuven, Belgium.
⁵ Department of Radiotherapy, Mount Vernon Centre for Cancer Treatment, Northwood, London, United Kingdom.
⁶ Department of Radiology, Radiation Oncology and Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica S. Cuore, Rome, Italy.
⁷ Department of Oncology, Aarhus University Hospital, Denmark.
⁸ Department of Oncology, Oslo University Hospital, Norway.
⁹ Department of Oncology, Sorbonne University, Paris, France.
¹⁰ Department of Radiotherapy, Universidad de Navarra, Madrid, Spain.
¹¹ Department of Radiotherapy, Champalimaud Foundation, Lisbon, Portugal.
¹² Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
¹³ Department of Radiotherapy, Leeds Cancer Centre, University of Leeds, UK.

No abstract available

Keywords: COVID 19; Radiotherapy; Rectal cancer.

Figures

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D; ESMO Guidelines Committee. Glynne-Jones R, et al. Ann Oncol. 2017 Jul 1;28(suppl_4):iv22-iv40. doi: 10.1093/annonc/mdx224. Ann Oncol. 2017. PMID: 28881920 No abstract available.

1. Glynne-Jones R., Wyrwicz L., Tiret E. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28 iv22-iv40. - PubMed
1. Ngan S.Y., Burmeister B., Fisher R.J. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol. 2012;30:3827–3833. - PubMed
1. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., Michalski W., Bebenek M., Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93:1215–1223. - PubMed
1. van Gijn W., Marijnen C.A., Nagtegaal I.D. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12:575–582. - PubMed
1. Sebag-Montefiore D., Stephens R.J., Steele R. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811–820. - PMC - PubMed